Stay updated on DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab

Sign up to get notified when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.
Latest website image capture
Clouds background image

Latest updates to the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page

  1. Check
    7 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and explains that the term “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    0.8%
    Check dated 2026-10-25T15:34:49.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:10:54.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:05:25.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry, v3.7.0, replacing the previous revision v3.6.6. This change represents an update to the page's version history rather than modifications to trial data or content.
    Difference
    0.1%
    Check dated 2026-09-20T20:59:59.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added and the previous v3.6.5 entry removed, indicating a platform update to the page's history.
    Difference
    0.1%
    Check dated 2026-08-30T15:33:45.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added to the page’s history and the previous revision v3.6.4 was removed from the history.
    Difference
    0.1%
    Check dated 2026-08-08T23:40:35.000Z thumbnail image

Stay in the know with updates to DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab

Enter your email address, and we'll notify you when there's something new on the DONIMI Clinical Trial: Neoadjuvant Domatinostat, Nivolumab, Ipilimumab page.